In November 2014, Reckitt, the manufacturer of 'MOOV' ointment aired an advertisement showing their product is twice more effective than Emami Limited's pain-relieving Zandu Balm. It further claimed that MOOV contained twice the number of active ingredients when compared to Zandu Balm and hence it is twice effective and stronger.
When, Emami moved to court, the Calcutta high court upheld an injunction on the advertisement issued by a district court in Calcutta. Challenging the Calcutta HC order, RB moved Supreme Court.
"Reckitt Benckiser, the defendant has been finally restrained by the Hon'ble Supreme Court from airing the impugned advertisement of MOOV pain ointment thus holding up Emami Limited's objection to the false claim about product superiority being made by Reckitt", Emami said in a statement.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)